The content is available as a PDF (333.8 KB).
letter . 2020 May 8:dgaa254. doi: 10.1210/clinem/dgaa254
Letter to the Editor: “Our Response to COVID-19 as Endocrinologists and Diabetologists”
Ruban Dhaliwal
1,✉, Sanjay K Bhadada
2, Sudhaker D Rao
3
Ruban Dhaliwal
1
Metabolic Bone Disease Center, State University of New York Upstate Medical University, Syracuse, NY
Find articles by Ruban Dhaliwal
Sanjay K Bhadada
2
Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
Find articles by Sanjay K Bhadada
Sudhaker D Rao
3
Divison of Endocrinology, Diabetes and Bone & Mineral Disorders, and Bone & Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI
Find articles by Sudhaker D Rao
1
Metabolic Bone Disease Center, State University of New York Upstate Medical University, Syracuse, NY
2
Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
3
Divison of Endocrinology, Diabetes and Bone & Mineral Disorders, and Bone & Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI
✉
Corresponding Author: Ruban Dhaliwal, MD, MPH, Metabolic Bone Disease Center, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, Phone: 315-464-5540, Email: dhaliwar@upstate.edu.
Received 2020 Apr 14.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7239144 PMID: 32382734
See "Our Response to COVID-19 as Endocrinologists and Diabetologists" in volume 105 on page 1299.